RENOVION
Chapel Hill
About RENOVION
Renovion company is a pharmaceutical corporation with therapy for chronic inflammatory airway diseases. The company’s flagship pharmaceutical product, Arina-1, is still in the pre-clinical stages. Renovion was formed in 2013 to leverage a pharmaceutical discovery at the University of North Carolina-Chapel Hill that reduces infection and addresses airway inflammation through the use of a novel therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $29.4M
- Last round: Series Unknown (Mar 2023)
- Website: renovion.com
- Phone: 919-240-7034
Industries & Categories
Clinical Trials, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/renovion-74667 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.